You are here » Home » Companies » Company Overview » Ankur Drugs & Pharma Ltd

Ankur Drugs & Pharma Ltd.

BSE: 531683 Sector: Health care
NSE: ANKURDRUGS ISIN Code: INE238D01012
BSE LIVE 05:30 | 01 Jan Stock Is Not Traded.
NSE LIVE 00:00 | 10 Sep Stock Is Not Traded.
OPEN
PREVIOUS CLOSE
VOLUME
52-Week high 0.00
52-Week low 0.00
P/E
Mkt Cap.(Rs cr)
Buy Price
Buy Qty
Sell Price
Sell Qty
OPEN
CLOSE
VOLUME
52-Week high 0.00
52-Week low 0.00
P/E
Mkt Cap.(Rs cr)
Buy Price
Buy Qty
Sell Price
Sell Qty

Ankur Drugs & Pharma Ltd. (ANKURDRUGS) - Company Information

Ankur Drugs & Pharma Ltd

Ankur Drugs and Pharma Ltd is engaged in contract manufacturing of pharmaceuticals formulations. The company has three manufacturing units: two in Himachal Pradesh and one in Daman. Its business segment includes pharmaceutical formulations in the form of tablets, capsules, liquid orals, oral powder, dry syrups, ointments, insta use suspension, form fill and seal (FFS), liquid injectables and dry p...> More

COMPANY INFORMATION
Chairman & Managing Director : Purnandu Jain
Whole Time Executive Director : Girraj Vijayvargiya
Director : Dileep Shinde
Director : Clifton Zimmermann
Company Secretary : S C Rane
Director : Ramesh Batham
AUDITOR : M G Vashi & Co
IND NAME : Pharmaceuticals - Indian - Formulations
HOUSE NAME : Indian Private
Registered office
C-306 Crystal Plaza, Andheri Link Road Andheri(W),Mumbai,Maharashtra-400053
Ph : 91-22-40682300
WEBSITE : http://www.ankurdrugs.com
E-mail : srane@ankurdrugs.com

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard